• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Illumina Faces Proxy Battle Over Grail Acquisition

Illumina Faces Proxy Battle Over Grail Acquisition

by Glenn S. Demby | Mar 30, 2023 | Essential, Industry Buzz-lir, Laboratory Industry Report

Carl Icahn has decided to take his beef with Illumina’s board of directors over the acquisition directly to company shareholders.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Amazon Closes One Medical Acquisition but FTC Intervention Looms

Amazon Closes One Medical Acquisition but FTC Intervention Looms

by Glenn S. Demby | Feb 28, 2023 | Essential, Industry Buzz-lir, Laboratory Industry Report

The deal closed Feb.22, but the FTC has expressed concerns about the acquisition and Amazon’s business practices in general.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Lab Companies See Massive Layoffs and Restructuring

by Glenn S. Demby | Jan 31, 2023 | Essential, Industry Buzz-lir, Laboratory Industry Report

Economic volatility and uncertainty is also making a significant impact on merger and acquisition activity in the diagnostics space.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The 5 Most Significant Lab Company M&A Deals of 2022

The 5 Most Significant Lab Company M&A Deals of 2022

by Glenn S. Demby | Jan 10, 2023 | News, Open Content

Merger and acquisition deal volume and value were down last year, but deal impact was not.

M&A Report: The Top 15 Diagnostic Deals of 2022

M&A Report: The Top 15 Diagnostic Deals of 2022

by Glenn S. Demby | Jan 3, 2023 | Essential, Industry Buzz-lir, Laboratory Industry Report

M&A activity in the clinical diagnostics space was significantly down in 2022 in terms of both deal volume and deal value.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com